{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:48:12Z","timestamp":1794109692499,"version":"4.8.0"},"reference-count":175,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1038\/s41569-026-01250-6","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:52:33Z","timestamp":1768409553000},"page":"473-485","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Procoagulant platelets: linking coagulation and thromboinflammation in cardiovascular disease"],"prefix":"10.1038","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1750-3395","authenticated-orcid":false,"given":"Rainer","family":"Kaiser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Nicolai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"1250_CR1","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41569-018-0110-0","volume":"16","author":"PEJ van der Meijden","year":"2019","unstructured":"van der Meijden, P. E. J. & Heemskerk, J. W. M. Platelet biology and functions: new concepts and clinical perspectives. Nat. Rev. Cardiol. 16, 166\u2013179 (2019).","journal-title":"Nat. Rev. Cardiol."},{"key":"1250_CR2","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/s41577-019-0202-z","volume":"19","author":"F Gaertner","year":"2019","unstructured":"Gaertner, F. & Massberg, S. Patrolling the vascular borders: platelets in immunity to infection and cancer. Nat. Rev. Immunol. 19, 747\u2013760 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"1250_CR3","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1084\/jem.20170879","volume":"214","author":"JL Li","year":"2017","unstructured":"Li, J. L., Zarbock, A. & Hidalgo, A. Platelets as autonomous drones for hemostatic and immune surveillance. J. Exp. Med. 214, 2193\u20132204 (2017).","journal-title":"J. Exp. Med."},{"key":"1250_CR4","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1182\/blood-2011-02-338244","volume":"118","author":"AA Schmaier","year":"2011","unstructured":"Schmaier, A. A. et al. Occlusive thrombi arise in mammals but not birds in response to arterial injury: evolutionary insight into human cardiovascular disease. Blood 118, 3661\u20133669 (2011).","journal-title":"Blood"},{"key":"1250_CR5","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.2515","volume":"17","author":"SP Jackson","year":"2011","unstructured":"Jackson, S. P. Arterial thrombosis \u2014 insidious, unpredictable and deadly. Nat. Med. 17, 1423\u20131436 (2011).","journal-title":"Nat. Med."},{"key":"1250_CR6","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD Diseases","year":"2020","unstructured":"Diseases, G. B. D. & Injuries, C. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396, 1204\u20131222 (2020).","journal-title":"Lancet"},{"key":"1250_CR7","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","volume":"44","author":"RA Byrne","year":"2023","unstructured":"Byrne, R. A. et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur. Heart J. 44, 3720\u20133826 (2023).","journal-title":"Eur. Heart J."},{"key":"1250_CR8","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1093\/eurheartj\/ehac706","volume":"44","author":"F Costa","year":"2023","unstructured":"Costa, F. et al. Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials. Eur. Heart J. 44, 954\u2013968 (2023).","journal-title":"Eur. Heart J."},{"key":"1250_CR9","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nm.2184","volume":"16","author":"S Massberg","year":"2010","unstructured":"Massberg, S. et al. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat. Med. 16, 887\u2013896 (2010).","journal-title":"Nat. Med."},{"key":"1250_CR10","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1084\/jem.20112322","volume":"209","author":"ML von Bruhl","year":"2012","unstructured":"von Bruhl, M. L. et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J. Exp. Med. 209, 819\u2013835 (2012).","journal-title":"J. Exp. Med."},{"key":"1250_CR11","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1182\/blood-2017-05-787259","volume":"130","author":"EO Agbani","year":"2017","unstructured":"Agbani, E. O. & Poole, A. W. Procoagulant platelets: generation, function, and therapeutic targeting in thrombosis. Blood 130, 2171\u20132179 (2017).","journal-title":"Blood"},{"key":"1250_CR12","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1161\/ATVBAHA.110.207522","volume":"30","author":"Z Li","year":"2010","unstructured":"Li, Z., Delaney, M. K., O\u2019Brien, K. A. & Du, X. Signaling during platelet adhesion and activation. Arterioscler. Thromb. Vasc. Biol. 30, 2341\u20132349 (2010).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1250_CR13","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1182\/blood.2024025320","volume":"146","author":"F Swieringa","year":"2025","unstructured":"Swieringa, F., Heemskerk, J. W. M. & Assinger, A. Platelet activation and signaling in thrombus formation. Blood 146, 1400\u20131411 (2025).","journal-title":"Blood"},{"key":"1250_CR14","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/jth.13302","volume":"14","author":"AP Bye","year":"2016","unstructured":"Bye, A. P., Unsworth, A. J. & Gibbins, J. M. Platelet signaling: a complex interplay between inhibitory and activatory networks. J. Thromb. Haemost. 14, 918\u2013930 (2016).","journal-title":"J. Thromb. Haemost."},{"key":"1250_CR15","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1182\/blood-2017-03-773614","volume":"130","author":"TN Durrant","year":"2017","unstructured":"Durrant, T. N., van den Bosch, M. T. & Hers, I. Integrin \u03b1IIb\u03b23 outside-in signaling. Blood 130, 1607\u20131619 (2017).","journal-title":"Blood"},{"key":"1250_CR16","doi-asserted-by":"publisher","first-page":"C951","DOI":"10.1152\/ajpcell.00252.2022","volume":"323","author":"F Denorme","year":"2022","unstructured":"Denorme, F. & Campbell, R. A. Procoagulant platelets: novel players in thromboinflammation. Am. J. Physiol. Cell Physiol. 323, C951\u2013C958 (2022).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"1250_CR17","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1161\/CIRCULATIONAHA.114.015036","volume":"132","author":"EO Agbani","year":"2015","unstructured":"Agbani, E. O. et al. Coordinated membrane ballooning and procoagulant spreading in human platelets. Circulation 132, 1414\u20131424 (2015). This study was among the first to offer a detailed imaging-based assessment of platelet procoagulant activity.","journal-title":"Circulation"},{"key":"1250_CR18","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1016\/j.jtha.2023.05.001","volume":"21","author":"EC Josefsson","year":"2023","unstructured":"Josefsson, E. C. et al. Consensus report on markers to distinguish procoagulant platelets from apoptotic platelets: communication from the Scientific and Standardization Committee of the ISTH. J. Thromb. Haemost. 21, 2291\u20132299 (2023).","journal-title":"J. Thromb. Haemost."},{"key":"1250_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1182\/blood.2021014914","volume":"140","author":"R Kaiser","year":"2022","unstructured":"Kaiser, R. et al. Procoagulant platelet sentinels prevent inflammatory bleeding through GPIIBIIIA and GPVI. Blood 140, 121\u2013139 (2022). This study provides in vivo and in vitro evidence on the physiological role of procoagulant activity in preventing inflammation-related bleeding.","journal-title":"Blood"},{"key":"1250_CR20","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1182\/blood-2009-01-200345","volume":"114","author":"SM Schoenwaelder","year":"2009","unstructured":"Schoenwaelder, S. M. et al. Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function. Blood 114, 663\u2013666 (2009). This study defines distinct molecular pathways of platelet apoptosis and procoagulant activation.","journal-title":"Blood"},{"key":"1250_CR21","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1182\/blood-2017-11-742684","volume":"131","author":"K McArthur","year":"2018","unstructured":"McArthur, K., Chappaz, S. & Kile, B. T. Apoptosis in megakaryocytes and platelets: the life and death of a lineage. Blood 131, 605\u2013610 (2018).","journal-title":"Blood"},{"key":"1250_CR22","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.cell.2007.01.037","volume":"128","author":"KD Mason","year":"2007","unstructured":"Mason, K. D. et al. Programmed anuclear cell death delimits platelet life span. Cell 128, 1173\u20131186 (2007).","journal-title":"Cell"},{"key":"1250_CR23","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1182\/blood.2024024901","volume":"145","author":"A Anjum","year":"2025","unstructured":"Anjum, A. et al. Aging platelets shift their hemostatic properties to inflammatory functions. Blood 145, 1568\u20131582 (2025). The authors of this study investigated platelet ageing phenotypes in mice and revealed increased procoagulant potential of aged platelets.","journal-title":"Blood"},{"key":"1250_CR24","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/415175a","volume":"415","author":"GL Dale","year":"2002","unstructured":"Dale, G. L. et al. Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature 415, 175\u2013179 (2002).","journal-title":"Nature"},{"key":"1250_CR25","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1182\/blood.V95.5.1694.005k24_1694_1702","volume":"95","author":"L Alberio","year":"2000","unstructured":"Alberio, L., Safa, O., Clemetson, K. J., Esmon, C. T. & Dale, G. L. Surface expression and functional characterization of alpha-granule factor V in human platelets: effects of ionophore A23187, thrombin, collagen, and convulxin. Blood 95, 1694\u20131702 (2000).","journal-title":"Blood"},{"key":"1250_CR26","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1080\/09537104.2020.1859103","volume":"32","author":"DI Fernandez","year":"2021","unstructured":"Fernandez, D. I., Kuijpers, M. J. E. & Heemskerk, J. W. M. Platelet calcium signaling by G-protein coupled and ITAM-linked receptors regulating anoctamin-6 and procoagulant activity. Platelets 32, 863\u2013871 (2021).","journal-title":"Platelets"},{"key":"1250_CR27","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1182\/blood-2016-02-696898","volume":"128","author":"NA Podoplelova","year":"2016","unstructured":"Podoplelova, N. A. et al. Coagulation factors bound to procoagulant platelets concentrate in cap structures to promote clotting. Blood 128, 1745\u20131755 (2016).","journal-title":"Blood"},{"key":"1250_CR28","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1182\/blood-2015-08-663005","volume":"126","author":"VM Hua","year":"2015","unstructured":"Hua, V. M. et al. Necrotic platelets provide a procoagulant surface during thrombosis. Blood 126, 2852\u20132862 (2015).","journal-title":"Blood"},{"key":"1250_CR29","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1182\/blood-2010-01-261669","volume":"116","author":"SP Jackson","year":"2010","unstructured":"Jackson, S. P. & Schoenwaelder, S. M. Procoagulant platelets: are they necrotic? Blood 116, 2011\u20132018 (2010).","journal-title":"Blood"},{"key":"1250_CR30","doi-asserted-by":"publisher","first-page":"e379","DOI":"10.3324\/haematol.2017.166819","volume":"102","author":"EO Agbani","year":"2017","unstructured":"Agbani, E. O., Hers, I. & Poole, A. W. Temporal contribution of the platelet body and balloon to thrombin generation. Haematologica 102, e379\u2013e381 (2017).","journal-title":"Haematologica"},{"key":"1250_CR31","doi-asserted-by":"publisher","first-page":"30697","DOI":"10.1074\/jbc.M403559200","volume":"279","author":"S Kulkarni","year":"2004","unstructured":"Kulkarni, S. & Jackson, S. P. Platelet factor XIII and calpain negatively regulate integrin alphaIIbbeta3 adhesive function and thrombus growth. J. Biol. Chem. 279, 30697\u201330706 (2004).","journal-title":"J. Biol. Chem."},{"key":"1250_CR32","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1182\/bloodadvances.2019000182","volume":"4","author":"N Abbasian","year":"2020","unstructured":"Abbasian, N., Millington-Burgess, S. L., Chabra, S., Malcor, J. D. & Harper, M. T. Supramaximal calcium signaling triggers procoagulant platelet formation. Blood Adv. 4, 154\u2013164 (2020).","journal-title":"Blood Adv."},{"key":"1250_CR33","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1182\/blood.2020008762","volume":"137","author":"K Althaus","year":"2021","unstructured":"Althaus, K. et al. Antibody-induced procoagulant platelets in severe COVID-19 infection. Blood 137, 1061\u20131071 (2021). This study identified increased numbers of procoagulant platelets in patients with severe COVID-19, which were associated with increased thrombotic events and mortality.","journal-title":"Blood"},{"key":"1250_CR34","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1182\/blood.V90.7.2615","volume":"90","author":"JW Heemskerk","year":"1997","unstructured":"Heemskerk, J. W., Vuist, W. M., Feijge, M. A., Reutelingsperger, C. P. & Lindhout, T. Collagen but not fibrinogen surfaces induce bleb formation, exposure of phosphatidylserine, and procoagulant activity of adherent platelets: evidence for regulation by protein tyrosine kinase-dependent Ca2+\u2009responses. Blood 90, 2615\u20132625 (1997).","journal-title":"Blood"},{"key":"1250_CR35","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1182\/blood-2007-05-092684","volume":"111","author":"SM Jobe","year":"2008","unstructured":"Jobe, S. M. et al. Critical role for the mitochondrial permeability transition pore and cyclophilin D in platelet activation and thrombosis. Blood 111, 1257\u20131265 (2008).","journal-title":"Blood"},{"key":"1250_CR36","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1182\/blood-2017-05-785253","volume":"132","author":"A Pang","year":"2018","unstructured":"Pang, A. et al. Shear-induced integrin signaling in platelet phosphatidylserine exposure, microvesicle release, and coagulation. Blood 132, 533\u2013543 (2018). In this study, shear stress was shown to be a key modulator of procoagulant activity.","journal-title":"Blood"},{"key":"1250_CR37","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1182\/blood-2014-03-560821","volume":"124","author":"MK Delaney","year":"2014","unstructured":"Delaney, M. K. et al. Agonist-induced platelet procoagulant activity requires shear and a Rac1-dependent signaling mechanism. Blood 124, 1957\u20131967 (2014).","journal-title":"Blood"},{"key":"1250_CR38","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1161\/ATVBAHA.117.309135","volume":"37","author":"AJ Unsworth","year":"2017","unstructured":"Unsworth, A. J. et al. Farnesoid X receptor and liver X receptor ligands initiate formation of coated platelets. Arterioscler. Thromb. Vasc. Biol. 37, 1482\u20131493 (2017).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1250_CR39","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jtha.2022.09.004","volume":"21","author":"JS Gauer","year":"2023","unstructured":"Gauer, J. S. et al. Fibrin\u2013glycoprotein VI interaction increases platelet procoagulant activity and impacts clot structure. J. Thromb. Haemost. 21, 667\u2013681 (2023).","journal-title":"J. Thromb. Haemost."},{"key":"1250_CR40","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1182\/blood-2015-04-641654","volume":"126","author":"OM Alshehri","year":"2015","unstructured":"Alshehri, O. M. et al. Fibrin activates GPVI in human and mouse platelets. Blood 126, 1601\u20131608 (2015).","journal-title":"Blood"},{"key":"1250_CR41","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1182\/blood-2015-02-629717","volume":"126","author":"E Mammadova-Bach","year":"2015","unstructured":"Mammadova-Bach, E. et al. Platelet glycoprotein VI binds to polymerized fibrin and promotes thrombin generation. Blood 126, 683\u2013691 (2015).","journal-title":"Blood"},{"key":"1250_CR42","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1182\/bloodadvances.2020001761","volume":"4","author":"M Nagy","year":"2020","unstructured":"Nagy, M. et al. Flow studies on human GPVI-deficient blood under coagulating and noncoagulating conditions. Blood Adv. 4, 2953\u20132961 (2020).","journal-title":"Blood Adv."},{"key":"1250_CR43","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1172\/JCI122955","volume":"129","author":"J Rayes","year":"2019","unstructured":"Rayes, J., Watson, S. P. & Nieswandt, B. Functional significance of the platelet immune receptors GPVI and CLEC-2. J. Clin. Invest. 129, 12\u201323 (2019).","journal-title":"J. Clin. Invest."},{"key":"1250_CR44","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/jth.13250","volume":"14","author":"RH Lee","year":"2016","unstructured":"Lee, R. H. & Bergmeier, W. Platelet immunoreceptor tyrosine-based activation motif (ITAM) and hemITAM signaling and vascular integrity in inflammation and development. J. Thromb. Haemost. 14, 645\u2013654 (2016).","journal-title":"J. Thromb. Haemost."},{"key":"1250_CR45","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1111\/jth.13293","volume":"14","author":"SL French","year":"2016","unstructured":"French, S. L. et al. Inhibition of protease-activated receptor 4 impairs platelet procoagulant activity during thrombus formation in human blood. J. Thromb. Haemost. 14, 1642\u20131654 (2016).","journal-title":"J. Thromb. Haemost."},{"key":"1250_CR46","doi-asserted-by":"publisher","first-page":"11189","DOI":"10.1073\/pnas.96.20.11189","volume":"96","author":"H Andersen","year":"1999","unstructured":"Andersen, H. et al. Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity. Proc. Natl Acad. Sci. USA 96, 11189\u201311193 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1250_CR47","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1172\/JCI6042","volume":"103","author":"ML Kahn","year":"1999","unstructured":"Kahn, M. L., Nakanishi-Matsui, M., Shapiro, M. J., Ishihara, H. & Coughlin, S. R. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J. Clin. Invest. 103, 879\u2013887 (1999).","journal-title":"J. Clin. Invest."},{"key":"1250_CR48","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1182\/blood.V97.10.3109","volume":"97","author":"M Riewald","year":"2001","unstructured":"Riewald, M. et al. Gene induction by coagulation factor Xa is mediated by activation of protease-activated receptor 1. Blood 97, 3109\u20133116 (2001).","journal-title":"Blood"},{"key":"1250_CR49","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.jtha.2024.12.031","volume":"23","author":"EA Knauss","year":"2025","unstructured":"Knauss, E. A. et al. Mice with reduced protease-activated receptor 4 reactivity show decreased venous thrombosis and platelet procoagulant activity. J. Thromb. Haemost. 23, 1278\u20131288 (2025).","journal-title":"J. Thromb. Haemost."},{"key":"1250_CR50","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1182\/blood.2021014966","volume":"140","author":"M Colicchia","year":"2022","unstructured":"Colicchia, M. et al. S100A8\/A9 drives the formation of procoagulant platelets through GPIb\u03b1. Blood 140, 2626\u20132643 (2022). This study linked neutrophil activation to procoagulant activity mediated by the action of S100A8\u2013S100A9 on platelets.","journal-title":"Blood"},{"key":"1250_CR51","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1182\/bloodadvances.2018025411","volume":"2","author":"M Yang","year":"2018","unstructured":"Yang, M. et al. Platelet CD36 signaling through ERK5 promotes caspase-dependent procoagulant activity and fibrin deposition in vivo. Blood Adv. 2, 2848\u20132861 (2018).","journal-title":"Blood Adv."},{"key":"1250_CR52","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1080\/09537104.2018.1501470","volume":"30","author":"G Mezei","year":"2019","unstructured":"Mezei, G. et al. Dasatinib inhibits coated-platelet generation in patients with chronic myeloid leukemia. Platelets 30, 836\u2013843 (2019).","journal-title":"Platelets"},{"key":"1250_CR53","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.cell.2007.11.028","volume":"131","author":"DE Clapham","year":"2007","unstructured":"Clapham, D. E. Calcium signaling. Cell 131, 1047\u20131058 (2007).","journal-title":"Cell"},{"key":"1250_CR54","doi-asserted-by":"publisher","first-page":"ra50","DOI":"10.1126\/scisignal.2003701","volume":"6","author":"MT Harper","year":"2013","unstructured":"Harper, M. T. et al. Transient receptor potential channels function as a coincidence signal detector mediating phosphatidylserine exposure. Sci. Signal. 6, ra50 (2013).","journal-title":"Sci. Signal."},{"key":"1250_CR55","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ceca.2018.11.005","volume":"77","author":"E Mammadova-Bach","year":"2019","unstructured":"Mammadova-Bach, E., Nagy, M., Heemskerk, J. W. M., Nieswandt, B. & Braun, A. Store-operated calcium entry in thrombosis and thrombo-inflammation. Cell Calcium 77, 39\u201348 (2019).","journal-title":"Cell Calcium"},{"key":"1250_CR56","doi-asserted-by":"publisher","first-page":"23629","DOI":"10.1074\/jbc.M110.108696","volume":"285","author":"K Gilio","year":"2010","unstructured":"Gilio, K. et al. Roles of platelet STIM1 and Orai1 in glycoprotein VI- and thrombin-dependent procoagulant activity and thrombus formation. J. Biol. Chem. 285, 23629\u201323638 (2010).","journal-title":"J. Biol. Chem."},{"key":"1250_CR57","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1182\/blood-2008-07-171611","volume":"113","author":"A Braun","year":"2009","unstructured":"Braun, A. et al. Orai1 (CRACM1) is the platelet SOC channel and essential for pathological thrombus formation. Blood 113, 2056\u20132063 (2009).","journal-title":"Blood"},{"key":"1250_CR58","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1111\/jth.14284","volume":"16","author":"A Kholmukhamedov","year":"2018","unstructured":"Kholmukhamedov, A., Janecke, R., Choo, H. J. & Jobe, S. M. The mitochondrial calcium uniporter regulates procoagulant platelet formation. J. Thromb. Haemost. 16, 2315\u20132321 (2018).","journal-title":"J. Thromb. Haemost."},{"key":"1250_CR59","doi-asserted-by":"publisher","first-page":"6064","DOI":"10.1172\/JCI136457","volume":"130","author":"J Volz","year":"2020","unstructured":"Volz, J. et al. BIN2 orchestrates platelet calcium signaling in thrombosis and thrombo-inflammation. J. Clin. Invest. 130, 6064\u20136079 (2020).","journal-title":"J. Clin. Invest."},{"key":"1250_CR60","doi-asserted-by":"publisher","first-page":"107899","DOI":"10.1016\/j.jbc.2024.107899","volume":"300","author":"J Zou","year":"2024","unstructured":"Zou, J. et al. Suppressed ORAI1-STIM1-dependent Ca(2+) entry by protein kinase C isoforms regulating platelet procoagulant activity. J. Biol. Chem. 300, 107899 (2024).","journal-title":"J. Biol. Chem."},{"key":"1250_CR61","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1161\/01.ATV.0000152726.49229.bf","volume":"25","author":"G Remenyi","year":"2005","unstructured":"Remenyi, G., Szasz, R., Friese, P. & Dale, G. L. Role of mitochondrial permeability transition pore in coated-platelet formation. Arterioscler. Thromb. Vasc. Biol. 25, 467\u2013471 (2005).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1250_CR62","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1161\/ATVBAHA.117.309473","volume":"37","author":"HJ Choo","year":"2017","unstructured":"Choo, H. J., Kholmukhamedov, A., Zhou, C. & Jobe, S. Inner mitochondrial membrane disruption links apoptotic and agonist-initiated phosphatidylserine externalization in platelets. Arterioscler. Thromb. Vasc. Biol. 37, 1503\u20131512 (2017).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1250_CR63","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/nature03434","volume":"434","author":"CP Baines","year":"2005","unstructured":"Baines, C. P. et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434, 658\u2013662 (2005).","journal-title":"Nature"},{"key":"1250_CR64","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1182\/blood.2024025476","volume":"144","author":"R Kaiser","year":"2024","unstructured":"Kaiser, R. et al. Procoagulant platelet activation promotes venous thrombosis. Blood 144, 2546\u20132553 (2024). Procoagulant platelets were shown to have an important role in venous thrombosis, identifying these platelets as a potential therapeutic target.","journal-title":"Blood"},{"key":"1250_CR65","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1182\/blood.2019002124","volume":"135","author":"F Denorme","year":"2020","unstructured":"Denorme, F. et al. Platelet necrosis mediates ischemic stroke outcome in mice. Blood 135, 429\u2013440 (2020). This study highlights the pathological role of platelet procoagulant activity and its interplay with neutrophils in stroke.","journal-title":"Blood"},{"key":"1250_CR66","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1161\/CIRCRESAHA.123.322914","volume":"134","author":"S Jacob","year":"2024","unstructured":"Jacob, S. et al. Mitofusin-2 regulates platelet mitochondria and function. Circ. Res. 134, 143\u2013161 (2024).","journal-title":"Circ. Res."},{"key":"1250_CR67","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1161\/ATVBAHA.112.300433","volume":"32","author":"HJ Choo","year":"2012","unstructured":"Choo, H. J., Saafir, T. B., Mkumba, L., Wagner, M. B. & Jobe, S. M. Mitochondrial calcium and reactive oxygen species regulate agonist-initiated platelet phosphatidylserine exposure. Arterioscler. Thromb. Vasc. Biol. 32, 2946\u20132955 (2012).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1250_CR68","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1182\/blood.V94.5.1683","volume":"94","author":"BB Wolf","year":"1999","unstructured":"Wolf, B. B. et al. Calpain functions in a caspase-independent manner to promote apoptosis-like events during platelet activation. Blood 94, 1683\u20131692 (1999).","journal-title":"Blood"},{"key":"1250_CR69","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1074\/jbc.272.3.1694","volume":"272","author":"SM Schoenwaelder","year":"1997","unstructured":"Schoenwaelder, S. M., Yuan, Y., Cooray, P., Salem, H. H. & Jackson, S. P. Calpain cleavage of focal adhesion proteins regulates the cytoskeletal attachment of integrin alphaIIbbeta3 (platelet glycoprotein IIb\/IIIa) and the cellular retraction of fibrin clots. J. Biol. Chem. 272, 1694\u20131702 (1997).","journal-title":"J. Biol. Chem."},{"key":"1250_CR70","doi-asserted-by":"publisher","first-page":"13325","DOI":"10.1074\/jbc.M112.428359","volume":"288","author":"NJ Mattheij","year":"2013","unstructured":"Mattheij, N. J. et al. Dual mechanism of integrin alphaIIbbeta3 closure in procoagulant platelets. J. Biol. Chem. 288, 13325\u201313336 (2013).","journal-title":"J. Biol. Chem."},{"key":"1250_CR71","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1172\/JCI69210","volume":"123","author":"C Deppermann","year":"2013","unstructured":"Deppermann, C. et al. Gray platelet syndrome and defective thrombo-inflammation in Nbeal2-deficient mice. J. Clin. Invest. 123, 3331\u20133342 (2013).","journal-title":"J. Clin. Invest."},{"key":"1250_CR72","doi-asserted-by":"publisher","DOI":"10.4161\/rdis.26561","volume":"1","author":"C Deppermann","year":"2013","unstructured":"Deppermann, C., Nurden, P., Nurden, A. T., Nieswandt, B. & Stegner, D. The Nbeal2(\u2212\/\u2212) mouse as a model for the gray platelet syndrome. Rare Dis. 1, e26561 (2013).","journal-title":"Rare Dis."},{"key":"1250_CR73","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nature09583","volume":"468","author":"J Suzuki","year":"2010","unstructured":"Suzuki, J., Umeda, M., Sims, P. J. & Nagata, S. Calcium-dependent phospholipid scrambling by TMEM16F. Nature 468, 834\u2013838 (2010).","journal-title":"Nature"},{"key":"1250_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34497-x","volume":"13","author":"M Arndt","year":"2022","unstructured":"Arndt, M. et al. Structural basis for the activation of the lipid scramblase TMEM16F. Nat. Commun. 13, 6692 (2022).","journal-title":"Nat. Commun."},{"key":"1250_CR75","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1096\/fj.15-280446","volume":"30","author":"NJ Mattheij","year":"2016","unstructured":"Mattheij, N. J. et al. Survival protein anoctamin-6 controls multiple platelet responses including phospholipid scrambling, swelling, and protein cleavage. FASEB J. 30, 727\u2013737 (2016).","journal-title":"FASEB J."},{"key":"1250_CR76","doi-asserted-by":"publisher","first-page":"12800","DOI":"10.1073\/pnas.1516594112","volume":"112","author":"T Fujii","year":"2015","unstructured":"Fujii, T., Sakata, A., Nishimura, S., Eto, K. & Nagata, S. TMEM16F is required for phosphatidylserine exposure and microparticle release in activated mouse platelets. Proc. Natl Acad. Sci. USA 112, 12800\u201312805 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1250_CR77","doi-asserted-by":"publisher","first-page":"13305","DOI":"10.1074\/jbc.M113.457937","volume":"288","author":"J Suzuki","year":"2013","unstructured":"Suzuki, J. et al. Calcium-dependent phospholipid scramblase activity of TMEM16 protein family members. J. Biol. Chem. 288, 13305\u201313316 (2013).","journal-title":"J. Biol. Chem."},{"key":"1250_CR78","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cell.2012.07.036","volume":"151","author":"H Yang","year":"2012","unstructured":"Yang, H. et al. TMEM16F forms a Ca2+-activated cation channel required for lipid scrambling in platelets during blood coagulation. Cell 151, 111\u2013122 (2012). This landmark study revealed TMEM16F as a key regulator required for platelet procoagulant activation.","journal-title":"Cell"},{"key":"1250_CR79","doi-asserted-by":"publisher","first-page":"5875","DOI":"10.1073\/pnas.1222419110","volume":"110","author":"SR Clark","year":"2013","unstructured":"Clark, S. R. et al. Characterization of platelet aminophospholipid externalization reveals fatty acids as molecular determinants that regulate coagulation. Proc. Natl Acad. Sci. USA 110, 5875\u20135880 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1250_CR80","doi-asserted-by":"publisher","first-page":"C748","DOI":"10.1152\/ajpcell.00228.2012","volume":"304","author":"T Shimizu","year":"2013","unstructured":"Shimizu, T. et al. TMEM16F is a component of a Ca2+-activated Cl\u2212 channel but not a volume-sensitive outwardly rectifying Cl- channel. Am. J. Physiol. Cell Physiol. 304, C748\u2013C759 (2013).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"1250_CR81","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.99062","volume":"3","author":"EO Agbani","year":"2018","unstructured":"Agbani, E. O. et al. Aquaporin-1 regulates platelet procoagulant membrane dynamics and in vivo thrombosis. JCI Insight 3, e99062 (2018). Aquaporin 1 was identified as a key membrane protein mediating platelet ballooning, showing that blocking procoagulant activation through inhibiting aquaporin 1 activity might be an antithrombotic strategy.","journal-title":"JCI Insight"},{"key":"1250_CR82","doi-asserted-by":"publisher","first-page":"13289","DOI":"10.1016\/S0021-9258(18)98837-X","volume":"266","author":"JE Fox","year":"1991","unstructured":"Fox, J. E., Austin, C. D., Reynolds, C. C. & Steffen, P. K. Evidence that agonist-induced activation of calpain causes the shedding of procoagulant-containing microvesicles from the membrane of aggregating platelets. J. Biol. Chem. 266, 13289\u201313295 (1991).","journal-title":"J. Biol. Chem."},{"key":"1250_CR83","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1161\/ATVBAHA.116.307727","volume":"36","author":"AA Baig","year":"2016","unstructured":"Baig, A. A. et al. TMEM16F-mediated platelet membrane phospholipid scrambling is critical for hemostasis and thrombosis but not thromboinflammation in mice \u2014 brief report. Arterioscler. Thromb. Vasc. Biol. 36, 2152\u20132157 (2016).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1250_CR84","doi-asserted-by":"publisher","first-page":"17444","DOI":"10.1073\/pnas.1904978116","volume":"116","author":"P Vulliamy","year":"2019","unstructured":"Vulliamy, P. et al. Histone H4 induces platelet ballooning and microparticle release during trauma hemorrhage. Proc. Natl Acad. Sci. USA 116, 17444\u201317449 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1250_CR85","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41586-019-1167-6","volume":"569","author":"C Silvestre-Roig","year":"2019","unstructured":"Silvestre-Roig, C. et al. Externalized histone H4 orchestrates chronic inflammation by inducing lytic cell death. Nature 569, 236\u2013240 (2019).","journal-title":"Nature"},{"key":"1250_CR86","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1111\/jth.12677","volume":"12","author":"F Semeraro","year":"2014","unstructured":"Semeraro, F., Ammollo, C. T., Esmon, N. L. & Esmon, C. T. Histones induce phosphatidylserine exposure and a procoagulant phenotype in human red blood cells. J. Thromb. Haemost. 12, 1697\u20131702 (2014).","journal-title":"J. Thromb. Haemost."},{"key":"1250_CR87","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1182\/blood-2011-03-343061","volume":"118","author":"F Semeraro","year":"2011","unstructured":"Semeraro, F. et al. Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood 118, 1952\u20131961 (2011).","journal-title":"Blood"},{"key":"1250_CR88","doi-asserted-by":"publisher","first-page":"30672","DOI":"10.1074\/jbc.M113.472688","volume":"288","author":"F Liu","year":"2013","unstructured":"Liu, F. et al. Mitochondrially mediated integrin alphaIIbbeta3 protein inactivation limits thrombus growth. J. Biol. Chem. 288, 30672\u201330681 (2013).","journal-title":"J. Biol. Chem."},{"key":"1250_CR89","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1161\/ATVBAHA.112.253765","volume":"32","author":"NN Topalov","year":"2012","unstructured":"Topalov, N. N. et al. Two types of procoagulant platelets are formed upon physiological activation and are controlled by integrin alpha(IIb)beta(3). Arterioscler. Thromb. Vasc. Biol. 32, 2475\u20132483 (2012).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1250_CR90","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.jtha.2024.01.004","volume":"22","author":"EM Guerreiro","year":"2024","unstructured":"Guerreiro, E. M. et al. Extracellular vesicles from activated platelets possess a phospholipid-rich biomolecular profile and enhance prothrombinase activity. J. Thromb. Haemost. 22, 1463\u20131474 (2024).","journal-title":"J. Thromb. Haemost."},{"key":"1250_CR91","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1182\/blood-2016-08-730622","volume":"128","author":"B Storrie","year":"2016","unstructured":"Storrie, B. A tip of the cap to procoagulant platelets. Blood 128, 1668\u20131669 (2016).","journal-title":"Blood"},{"key":"1250_CR92","doi-asserted-by":"publisher","first-page":"29621","DOI":"10.1074\/jbc.M113.474163","volume":"288","author":"AA Abaeva","year":"2013","unstructured":"Abaeva, A. A. et al. Procoagulant platelets form an alpha-granule protein-covered \u2018cap\u2019 on their surface that promotes their attachment to aggregates. J. Biol. Chem. 288, 29621\u201329632 (2013).","journal-title":"J. Biol. Chem."},{"key":"1250_CR93","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1161\/ATVBAHA.110.216531","volume":"30","author":"AM Fager","year":"2010","unstructured":"Fager, A. M., Wood, J. P., Bouchard, B. A., Feng, P. & Tracy, P. B. Properties of procoagulant platelets: defining and characterizing the subpopulation binding a functional prothrombinase. Arterioscler. Thromb. Vasc. Biol. 30, 2400\u20132407 (2010).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1250_CR94","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010415","volume":"5","author":"MA Berny","year":"2010","unstructured":"Berny, M. A. et al. Spatial distribution of factor Xa, thrombin, and fibrin(ogen) on thrombi at venous shear. PLoS ONE 5, e10415 (2010).","journal-title":"PLoS ONE"},{"key":"1250_CR95","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/jth.15154","volume":"19","author":"F Denorme","year":"2021","unstructured":"Denorme, F., Portier, I., Kosaka, Y. & Campbell, R. A. Hyperglycemia exacerbates ischemic stroke outcome independent of platelet glucose uptake. J. Thromb. Haemost. 19, 536\u2013546 (2021).","journal-title":"J. Thromb. Haemost."},{"key":"1250_CR96","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1161\/CIRCULATIONAHA.113.005224","volume":"129","author":"WH Tang","year":"2014","unstructured":"Tang, W. H. et al. Aldose reductase-mediated phosphorylation of p53 leads to mitochondrial dysfunction and damage in diabetic platelets. Circulation 129, 1598\u20131609 (2014).","journal-title":"Circulation"},{"key":"1250_CR97","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1182\/blood-2010-01-262683","volume":"117","author":"JM Cosemans","year":"2011","unstructured":"Cosemans, J. M. et al. Key role of glycoprotein Ib\/V\/IX and von Willebrand factor in platelet activation-dependent fibrin formation at low shear flow. Blood 117, 651\u2013660 (2011).","journal-title":"Blood"},{"key":"1250_CR98","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1161\/ATVBAHA.118.311390","volume":"39","author":"DY Nechipurenko","year":"2019","unstructured":"Nechipurenko, D. Y. et al. Clot contraction drives the translocation of procoagulant platelets to thrombus surface. Arterioscler. Thromb. Vasc. Biol. 39, 37\u201347 (2019).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1250_CR99","doi-asserted-by":"publisher","first-page":"e287","DOI":"10.1161\/ATVBAHA.119.313468","volume":"39","author":"EO Agbani","year":"2019","unstructured":"Agbani, E. O., Hers, I. & Poole, A. W. Letter by Agbani et al regarding article, \u2018Clot contraction drives the translocation of procoagulant platelets to thrombus surface\u2019. Arterioscler. Thromb. Vasc. Biol. 39, e287\u2013e289 (2019).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1250_CR100","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1182\/blood.2023022608","volume":"144","author":"A Ballard-Kordeliski","year":"2024","unstructured":"Ballard-Kordeliski, A. et al. 4D intravital imaging studies identify platelets as the predominant cellular procoagulant surface in a mouse hemostasis model. Blood 144, 1116\u20131126 (2024).","journal-title":"Blood"},{"key":"1250_CR101","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1111\/jth.14008","volume":"16","author":"L Pasalic","year":"2018","unstructured":"Pasalic, L. et al. Novel assay demonstrates that coronary artery disease patients have heightened procoagulant platelet response. J. Thromb. Haemost. 16, 1198\u20131210 (2018).","journal-title":"J. Thromb. Haemost."},{"key":"1250_CR102","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1161\/ATVBAHA.123.320615","volume":"44","author":"T Feige","year":"2024","unstructured":"Feige, T. et al. GP VI-mediated platelet activation and procoagulant activity aggravate inflammation and aortic wall remodeling in abdominal aortic aneurysm. Arterioscler. Thromb. Vasc. Biol. 44, 2294\u20132317 (2024).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1250_CR103","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1538-7836.2011.04544.x","volume":"10","author":"A Brill","year":"2012","unstructured":"Brill, A. et al. Neutrophil extracellular traps promote deep vein thrombosis in mice. J. Thromb. Haemost. 10, 136\u2013144 (2012).","journal-title":"J. Thromb. Haemost."},{"key":"1250_CR104","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1182\/blood-2010-05-287623","volume":"117","author":"A Brill","year":"2011","unstructured":"Brill, A. et al. von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models. Blood 117, 1400\u20131407 (2011).","journal-title":"Blood"},{"key":"1250_CR105","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/jth.15569","volume":"20","author":"RH Lee","year":"2022","unstructured":"Lee, R. H. et al. Genetic deletion of platelet PAR4 results in reduced thrombosis and impaired hemostatic plug stability. J. Thromb. Haemost. 20, 422\u2013433 (2022).","journal-title":"J. Thromb. Haemost."},{"key":"1250_CR106","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1182\/blood.2023022522","volume":"144","author":"J Rayes","year":"2024","unstructured":"Rayes, J. & Brill, A. Hot under the clot: venous thrombogenesis is an inflammatory process. Blood 144, 477\u2013489 (2024).","journal-title":"Blood"},{"key":"1250_CR107","doi-asserted-by":"publisher","first-page":"8674","DOI":"10.1073\/pnas.1301059110","volume":"110","author":"K Martinod","year":"2013","unstructured":"Martinod, K. et al. Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in mice. Proc. Natl Acad. Sci. USA 110, 8674\u20138679 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1250_CR108","doi-asserted-by":"publisher","first-page":"15880","DOI":"10.1073\/pnas.1005743107","volume":"107","author":"TA Fuchs","year":"2010","unstructured":"Fuchs, T. A. et al. Extracellular DNA traps promote thrombosis. Proc. Natl Acad. Sci. USA 107, 15880\u201315885 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1250_CR109","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1182\/blood-2016-04-710632","volume":"128","author":"K Stark","year":"2016","unstructured":"Stark, K. et al. Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice. Blood 128, 2435\u20132449 (2016).","journal-title":"Blood"},{"key":"1250_CR110","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1016\/j.immuni.2024.08.007","volume":"57","author":"K Stark","year":"2024","unstructured":"Stark, K. et al. Antibodies and complement are key drivers of thrombosis. Immunity 57, 2140\u20132156.e2110 (2024).","journal-title":"Immunity"},{"key":"1250_CR111","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/S0140-6736(24)00685-8","volume":"403","author":"GBD 2021 Forecasting Collaborators","year":"2024","unstructured":"GBD 2021 Forecasting Collaborators. Burden of disease scenarios for 204 countries and territories, 2022\u20132050: a forecasting analysis for the Global Burden of Disease Study 2021. Lancet 403, 2204\u20132256 (2024).","journal-title":"Lancet"},{"key":"1250_CR112","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/jth.14714","volume":"18","author":"AC Kirkpatrick","year":"2020","unstructured":"Kirkpatrick, A. C., Vincent, A. S., Dale, G. L. & Prodan, C. I. Increased platelet procoagulant potential predicts recurrent stroke and TIA after lacunar infarction. J Thromb. Haemost. 18, 660\u2013668 (2020).","journal-title":"J Thromb. Haemost."},{"key":"1250_CR113","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.06.033","volume":"28","author":"AC Kirkpatrick","year":"2019","unstructured":"Kirkpatrick, A.C., Stoner, J. A., Dale, G. L., Rabadi, M. & Prodan, C. I. Higher coated-platelet levels in acute stroke are associated with lower cognitive scores at three months post infarction. J. Stroke Cerebrovasc. Dis. 28, 2398\u20132406 (2019).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"1250_CR114","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1212\/WNL.0000000000004090","volume":"89","author":"AC Kirkpatrick","year":"2017","unstructured":"Kirkpatrick, A. C., Vincent, A. S., Dale, G. L. & Prodan, C. I. Coated-platelets predict stroke at 30 days following TIA. Neurology 89, 125\u2013128 (2017).","journal-title":"Neurology"},{"key":"1250_CR115","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1111\/jth.13160","volume":"13","author":"CI Prodan","year":"2015","unstructured":"Prodan, C. I., Stoner, J. A. & Dale, G. L. Acute hemorrhagic complications are associated with lower coated-platelet levels in non-lacunar brain infarction. J. Thromb. Haemost. 13, 2233\u20132239 (2015).","journal-title":"J. Thromb. Haemost."},{"key":"1250_CR116","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1161\/STROKEAHA.114.006492","volume":"45","author":"AC Kirkpatrick","year":"2014","unstructured":"Kirkpatrick, A. C., Tafur, A. J., Vincent, A. S., Dale, G. L. & Prodan, C. I. Coated-platelets improve prediction of stroke and transient ischemic attack in asymptomatic internal carotid artery stenosis. Stroke 45, 2995\u20133001 (2014).","journal-title":"Stroke"},{"key":"1250_CR117","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/jcbfm.2012.168","volume":"33","author":"CI Prodan","year":"2013","unstructured":"Prodan, C. I., Stoner, J. A., Cowan, L. D. & Dale, G. L. Higher coated-platelet levels are associated with stroke recurrence following nonlacunar brain infarction. J. Cereb. Blood Flow Metab. 33, 287\u2013292 (2013).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"1250_CR118","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1161\/STROKEAHA.109.549014","volume":"40","author":"CI Prodan","year":"2009","unstructured":"Prodan, C. I., Vincent, A. S., Padmanabhan, R. & Dale, G. L. Coated-platelet levels are low in patients with spontaneous intracerebral hemorrhage. Stroke 40, 2578\u20132580 (2009).","journal-title":"Stroke"},{"key":"1250_CR119","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1538-7836.2008.02890.x","volume":"6","author":"CI Prodan","year":"2008","unstructured":"Prodan, C. I., Joseph, P. M., Vincent, A. S. & Dale, G. L. Coated-platelets in ischemic stroke: differences between lacunar and cortical stroke. J. Thromb. Haemost. 6, 609\u2013614 (2008).","journal-title":"J. Thromb. Haemost."},{"key":"1250_CR120","doi-asserted-by":"publisher","DOI":"10.1172\/JCI154225","volume":"132","author":"F Denorme","year":"2022","unstructured":"Denorme, F. et al. Neutrophil extracellular traps regulate ischemic stroke brain injury. J. Clin. Invest. 132, e154225 (2022).","journal-title":"J. Clin. Invest."},{"key":"1250_CR121","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.immuni.2024.04.008","volume":"57","author":"L Nicolai","year":"2024","unstructured":"Nicolai, L., Pekayvaz, K. & Massberg, S. Platelets: orchestrators of immunity in host defense and beyond. Immunity 57, 957\u2013972 (2024).","journal-title":"Immunity"},{"key":"1250_CR122","doi-asserted-by":"publisher","first-page":"824112","DOI":"10.3389\/fcvm.2021.824112","volume":"8","author":"R Kaiser","year":"2021","unstructured":"Kaiser, R., Escaig, R., Erber, J. & Nicolai, L. Neutrophil\u2013platelet interactions as novel treatment targets in cardiovascular disease. Front. Cardiovasc. Med. 8, 824112 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"1250_CR123","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/s41569-021-00552-1","volume":"18","author":"K Stark","year":"2021","unstructured":"Stark, K. & Massberg, S. Interplay between inflammation and thrombosis in cardiovascular pathology. Nat. Rev. Cardiol. 18, 666\u2013682 (2021).","journal-title":"Nat. Rev. Cardiol."},{"key":"1250_CR124","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri3345","volume":"13","author":"B Engelmann","year":"2013","unstructured":"Engelmann, B. & Massberg, S. Thrombosis as an intravascular effector of innate immunity. Nat. Rev. Immunol. 13, 34\u201345 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"1250_CR125","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1182\/blood-2015-11-680744","volume":"127","author":"TA Claushuis","year":"2016","unstructured":"Claushuis, T. A. et al. Thrombocytopenia is associated with a dysregulated host response in critically ill sepsis patients. Blood 127, 3062\u20133072 (2016).","journal-title":"Blood"},{"key":"1250_CR126","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1182\/blood-2006-08-040980","volume":"110","author":"S Kulkarni","year":"2007","unstructured":"Kulkarni, S., Woollard, K. J., Thomas, S., Oxley, D. & Jackson, S. P. Conversion of platelets from a proaggregatory to a proinflammatory adhesive phenotype: role of PAF in spatially regulating neutrophil adhesion and spreading. Blood 110, 1879\u20131886 (2007).","journal-title":"Blood"},{"key":"1250_CR127","doi-asserted-by":"publisher","first-page":"eaam5861","DOI":"10.1126\/scitranslmed.aam5861","volume":"9","author":"Y Yuan","year":"2017","unstructured":"Yuan, Y. et al. Neutrophil macroaggregates promote widespread pulmonary thrombosis after gut ischemia. Sci. Transl. Med. 9, eaam5861 (2017). This landmark study showed a key role of procoagulant platelets in driving ischaemia\u2013reperfusion injury.","journal-title":"Sci. Transl. Med."},{"key":"1250_CR128","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1161\/ATVBAHA.122.318767","volume":"43","author":"C Schonichen","year":"2023","unstructured":"Schonichen, C. et al. Antagonistic roles of human platelet integrin alphaIIbbeta3 and chemokines in regulating neutrophil activation and fate on arterial thrombi under flow. Arterioscler. Thromb. Vasc. Biol. 43, 1700\u20131712 (2023).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1250_CR129","doi-asserted-by":"publisher","DOI":"10.1055\/a-2523-1821","author":"R Kaiser","year":"2025","unstructured":"Kaiser, R., Gold, C. & Stark, K. Recent advances in immunothrombosis and thromboinflammation. Thromb. Haemost. https:\/\/doi.org\/10.1055\/a-2523-1821 (2025).","journal-title":"Thromb. Haemost."},{"key":"1250_CR130","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/jth.15587","volume":"20","author":"L Pelzl","year":"2021","unstructured":"Pelzl, L. et al. Antibody-mediated procoagulant platelet formation in COVID-19 is AKT dependent. J. Thromb. Haemost. 20, 387\u2013398 (2021).","journal-title":"J. Thromb. Haemost."},{"key":"1250_CR131","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1182\/bloodadvances.2021005210","volume":"6","author":"J Zlamal","year":"2022","unstructured":"Zlamal, J. et al. Upregulation of cAMP prevents antibody-mediated thrombus formation in COVID-19. Blood Adv. 6, 248\u2013258 (2022).","journal-title":"Blood Adv."},{"key":"1250_CR132","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1111\/jth.15107","volume":"18","author":"F Denorme","year":"2020","unstructured":"Denorme, F. et al. COVID-19 patients exhibit reduced procoagulant platelet responses. J. Thromb. Haemost. 18, 3067\u20133073 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"1250_CR133","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1161\/CIRCULATIONAHA.120.048488","volume":"142","author":"L Nicolai","year":"2020","unstructured":"Nicolai, L. et al. Immunothrombotic dysregulation in COVID-19 pneumonia is associated with respiratory failure and coagulopathy. Circulation 142, 1176\u20131189 (2020).","journal-title":"Circulation"},{"key":"1250_CR134","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1182\/blood.2021013231","volume":"138","author":"A Greinacher","year":"2021","unstructured":"Greinacher, A. et al. Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia. Blood 138, 2256\u20132268 (2021).","journal-title":"Blood"},{"key":"1250_CR135","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.3324\/haematol.2021.279000","volume":"106","author":"K Althaus","year":"2021","unstructured":"Althaus, K. et al. Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia. Haematologica 106, 2170\u20132179 (2021).","journal-title":"Haematologica"},{"key":"1250_CR136","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.1182\/bloodadvances.2021006698","volume":"6","author":"CSM Lee","year":"2022","unstructured":"Lee, C. S. M. et al. A novel flow cytometry procoagulant assay for diagnosis of vaccine-induced immune thrombotic thrombocytopenia. Blood Adv. 6, 3494\u20133506 (2022).","journal-title":"Blood Adv."},{"key":"1250_CR137","doi-asserted-by":"publisher","first-page":"4323","DOI":"10.1182\/bloodadvances.2024015076","volume":"9","author":"M Esefeld","year":"2025","unstructured":"Esefeld, M. et al. Platelet activating histone\/antihistone IgG complexes in anti-PF4 negative thrombosis and thrombocytopenia syndrome. Blood Adv. 9, 4323\u20134335 (2025).","journal-title":"Blood Adv."},{"key":"1250_CR138","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1056\/NEJMcp1411910","volume":"373","author":"A Greinacher","year":"2015","unstructured":"Greinacher, A. CLINICAL PRACTICE. Heparin-induced thrombocytopenia. N. Engl. J. Med. 373, 252\u2013261 (2015).","journal-title":"N. Engl. J. Med."},{"key":"1250_CR139","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1055\/s-0043-1761269","volume":"49","author":"MV Selvadurai","year":"2023","unstructured":"Selvadurai, M. V., Favaloro, E. J. & Chen, V. M. Mechanisms of thrombosis in heparin-induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia. Semin. Thromb. Hemost. 49, 444\u2013452 (2023).","journal-title":"Semin. Thromb. Hemost."},{"key":"1250_CR140","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41586-021-03744-4","volume":"596","author":"A Huynh","year":"2021","unstructured":"Huynh, A., Kelton, J. G., Arnold, D. M., Daka, M. & Nazy, I. Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia. Nature 596, 565\u2013569 (2021).","journal-title":"Nature"},{"key":"1250_CR141","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41420-019-0188-0","volume":"5","author":"TA Nevzorova","year":"2019","unstructured":"Nevzorova, T. A. et al. Platelet factor 4-containing immune complexes induce platelet activation followed by calpain-dependent platelet death. Cell Death Discov. 5, 106 (2019).","journal-title":"Cell Death Discov."},{"key":"1250_CR142","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.jtha.2023.10.003","volume":"22","author":"L Pelzl","year":"2024","unstructured":"Pelzl, L. et al. Heparin-activated procoagulant platelet assay: a flow cytometry-based functional test for heparin-induced thrombocytopenia. J. Thromb. Haemost. 22, 470\u2013479 (2024).","journal-title":"J. Thromb. Haemost."},{"key":"1250_CR143","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.3324\/haematol.2022.282275","volume":"108","author":"J Zlamal","year":"2023","unstructured":"Zlamal, J. et al. Platelet phosphatidylserine is the critical mediator of thrombosis in heparin-induced thrombocytopenia. Haematologica 108, 2690\u20132702 (2023).\u00a0Procoagulant activity was shown to have a key role in HIT pathophysiology.","journal-title":"Haematologica"},{"key":"1250_CR144","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09160-7","volume":"10","author":"J Perdomo","year":"2019","unstructured":"Perdomo, J. et al. Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia. Nat. Commun. 10, 1322 (2019).","journal-title":"Nat. Commun."},{"key":"1250_CR145","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1182\/blood.2023020535","volume":"142","author":"R Kaiser","year":"2023","unstructured":"Kaiser, R., Escaig, R. & Nicolai, L. Hemostasis without clot formation \u2014 how platelets guard the vasculature in inflammation, infection, and malignancy. Blood 142, 1413\u20131425 (2023).","journal-title":"Blood"},{"key":"1250_CR146","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/jth.14714","volume":"18","author":"AC Kirkpatrick","year":"2020","unstructured":"Kirkpatrick, A. C., Vincent, A. S., Dale, G. L. & Prodan, C. I. Increased platelet procoagulant potential predicts recurrent stroke and TIA after lacunar infarction. J. Thromb. Haemost. 18, 660\u2013668 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"1250_CR147","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/j.1538-7836.2007.02461.x","volume":"5","author":"T Chung","year":"2007","unstructured":"Chung, T. et al. Platelet activation in acute pulmonary embolism. J. Thromb. Haemost. 5, 918\u2013924 (2007).","journal-title":"J. Thromb. Haemost."},{"key":"1250_CR148","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1055\/s-0036-1572328","volume":"42","author":"L Pasalic","year":"2016","unstructured":"Pasalic, L., Wang, S. S. & Chen, V. M. Platelets as biomarkers of coronary artery disease. Semin. Thromb. Hemost. 42, 223\u2013233 (2016).","journal-title":"Semin. Thromb. Hemost."},{"key":"1250_CR149","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/S0735-1097(98)00635-4","volume":"33","author":"KA Ault","year":"1999","unstructured":"Ault, K. A. et al. Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trial. Thrombolysis in myocardial infarction. J. Am. Coll. Cardiol. 33, 634\u2013639 (1999).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1250_CR150","first-page":"2973","volume":"141","author":"R Kaiser","year":"2023","unstructured":"Kaiser, R. et al. Mechanosensing via a GpIIb\/Src\/14-3-3zeta axis critically regulates platelet migration in vascular inflammation. Blood 141, 2973\u20132992 (2023).","journal-title":"Blood"},{"key":"1250_CR151","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12173","volume":"10","author":"L Rausch","year":"2021","unstructured":"Rausch, L. et al. Binding of phosphatidylserine-positive microparticles by PBMCs classifies disease severity in COVID-19 patients. J. Extracell. Vesicles 10, e12173 (2021).","journal-title":"J. Extracell. Vesicles"},{"key":"1250_CR152","doi-asserted-by":"publisher","first-page":"1792683","DOI":"10.1080\/20013078.2020.1792683","volume":"9","author":"J Kranich","year":"2020","unstructured":"Kranich, J. et al. In vivo identification of apoptotic and extracellular vesicle-bound live cells using image-based deep learning. J. Extracell. Vesicles 9, 1792683 (2020).","journal-title":"J. Extracell. Vesicles"},{"key":"1250_CR153","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1182\/bloodadvances.2022008122","volume":"7","author":"EO Agbani","year":"2023","unstructured":"Agbani, E. O., Hers, I. & Poole, A. W. Platelet procoagulant membrane dynamics: a key distinction between thrombosis and hemostasis? Blood Adv. 7, 1615\u20131619 (2023).","journal-title":"Blood Adv."},{"key":"1250_CR154","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19515-0","volume":"11","author":"L Nicolai","year":"2020","unstructured":"Nicolai, L. et al. Vascular surveillance by haptotactic blood platelets in inflammation and infection. Nat. Commun. 11, 5778 (2020).","journal-title":"Nat. Commun."},{"key":"1250_CR155","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1080\/09537104.2019.1693039","volume":"31","author":"SL Millington-Burgess","year":"2020","unstructured":"Millington-Burgess, S. L. & Harper, M. T. Gene of the issue: ANO6 and Scott syndrome. Platelets 31, 964\u2013967 (2020).","journal-title":"Platelets"},{"key":"1250_CR156","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1182\/blood.V87.4.1409.bloodjournal8741409","volume":"87","author":"F Toti","year":"1996","unstructured":"Toti, F., Satta, N., Fressinaud, E., Meyer, D. & Freyssinet, J. M. Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complications, is an inherited disorder. Blood 87, 1409\u20131415 (1996).","journal-title":"Blood"},{"key":"1250_CR157","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1111\/j.1538-7836.2008.03010.x","volume":"6","author":"J Shi","year":"2008","unstructured":"Shi, J., Pipe, S. W., Rasmussen, J. T., Heegaard, C. W. & Gilbert, G. E. Lactadherin blocks thrombosis and hemostasis in vivo: correlation with platelet phosphatidylserine exposure. J. Thromb. Haemost. 6, 1167\u20131174 (2008).","journal-title":"J. Thromb. Haemost."},{"key":"1250_CR158","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1160\/TH06-08-0436","volume":"97","author":"FA Kuypers","year":"2007","unstructured":"Kuypers, F. A., Larkin, S. K., Emeis, J. J. & Allison, A. C. Interaction of an annexin V homodimer (Diannexin) with phosphatidylserine on cell surfaces and consequent antithrombotic activity. Thromb. Haemost. 97, 478\u2013486 (2007).","journal-title":"Thromb. Haemost."},{"key":"1250_CR159","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/j.1538-7836.2012.04716.x","volume":"10","author":"ML Rand","year":"2012","unstructured":"Rand, M. L. et al. Diannexin, an annexin A5 homodimer, binds phosphatidylserine with high affinity and is a potent inhibitor of platelet-mediated events during thrombus formation. J. Thromb. Haemost. 10, 1109\u20131119 (2012).","journal-title":"J. Thromb. Haemost."},{"key":"1250_CR160","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1161\/01.CIR.96.7.2339","volume":"96","author":"P Thiagarajan","year":"1997","unstructured":"Thiagarajan, P. & Benedict, C. R. Inhibition of arterial thrombosis by recombinant annexin V in a rabbit carotid artery injury model. Circulation 96, 2339\u20132347 (1997).","journal-title":"Circulation"},{"key":"1250_CR161","doi-asserted-by":"publisher","first-page":"6670","DOI":"10.1074\/jbc.RA118.006044","volume":"294","author":"J Jing","year":"2019","unstructured":"Jing, J. & Sun, Y. An alpha(IIb)beta(3)- and phosphatidylserine (PS)-binding recombinant fusion protein promotes PS-dependent anticoagulation and integrin-dependent antithrombosis. J. Biol. Chem. 294, 6670\u20136684 (2019).","journal-title":"J. Biol. Chem."},{"key":"1250_CR162","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jtha.2024.10.007","volume":"23","author":"JGT Wurtzel","year":"2024","unstructured":"Wurtzel, J. G. T. et al. Phosphatidylserine-blocking nanoparticles inhibit thrombosis without increased bleeding in mice. J. Thromb. Haemost. 23, 108\u2013122 (2024).","journal-title":"J. Thromb. Haemost."},{"key":"1250_CR163","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1111\/jth.15641","volume":"20","author":"SL Millington-Burgess","year":"2022","unstructured":"Millington-Burgess, S. L. & Harper, M. T. Maintaining flippase activity in procoagulant platelets is a novel approach to reducing thrombin generation. J. Thromb. Haemost. 20, 989\u2013995 (2022).","journal-title":"J. Thromb. Haemost."},{"key":"1250_CR164","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrd4226","volume":"13","author":"AS Verkman","year":"2014","unstructured":"Verkman, A. S., Anderson, M. O. & Papadopoulos, M. C. Aquaporins: important but elusive drug targets. Nat. Rev. Drug Discov. 13, 259\u2013277 (2014).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1250_CR165","doi-asserted-by":"publisher","first-page":"4582","DOI":"10.1093\/eurheartj\/ehae482","volume":"45","author":"S Navarro","year":"2024","unstructured":"Navarro, S. et al. The humanized platelet glycoprotein VI Fab inhibitor EMA601 protects from arterial thrombosis and ischaemic stroke in mice. Eur. Heart J. 45, 4582\u20134597 (2024).","journal-title":"Eur. Heart J."},{"key":"1250_CR166","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.atherosclerosis.2020.07.015","volume":"310","author":"ACA Heinzmann","year":"2020","unstructured":"Heinzmann, A. C. A. et al. Complementary roles of platelet \u03b1IIb\u03b23 integrin, phosphatidylserine exposure and cytoskeletal rearrangement in the release of extracellular vesicles. Atherosclerosis 310, 17\u201325 (2020).","journal-title":"Atherosclerosis"},{"key":"1250_CR167","first-page":"2203","volume":"385","author":"C Weber","year":"2021","unstructured":"Weber, C., von Hundelshausen, P. & Siess, W. VITT after ChAdOx1 nCoV-19 vaccination. N. Engl. J. Med. 385, 2203\u20132204 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1250_CR168","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1182\/bloodadvances.2022007169","volume":"7","author":"TJ Zheng","year":"2023","unstructured":"Zheng, T. J. et al. Effect of antiplatelet agents and tyrosine kinase inhibitors on oxLDL-mediated procoagulant platelet activity. Blood Adv. 7, 1366\u20131378 (2023).","journal-title":"Blood Adv."},{"key":"1250_CR169","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1182\/bloodadvances.2024014785","volume":"9","author":"K Althaus","year":"2025","unstructured":"Althaus, K. et al. Platelet potential to switch to procoagulant phenotype compensates bleeding tendency in patients with hemophilia A. Blood Adv. 9, 1181\u20131184 (2025).","journal-title":"Blood Adv."},{"key":"1250_CR170","doi-asserted-by":"publisher","first-page":"eabb8975","DOI":"10.1126\/scitranslmed.abb8975","volume":"14","author":"UDS Sekhon","year":"2022","unstructured":"Sekhon, U. D. S. et al. Platelet-mimicking procoagulant nanoparticles augment hemostasis in animal models of bleeding. Sci. Transl. Med. 14, eabb8975 (2022). This study used procoagulant-platelet-mimicking nanoparticles to improve haemostasis in animal models.","journal-title":"Sci. Transl. Med."},{"key":"1250_CR171","first-page":"2891","volume":"141","author":"S Roullet","year":"2023","unstructured":"Roullet, S. et al. Efficacy of platelet-inspired hemostatic nanoparticles on bleeding in Von Willebrand disease murine models. Blood 141, 2891\u20132900 (2023).","journal-title":"Blood"},{"key":"1250_CR172","doi-asserted-by":"publisher","first-page":"16292","DOI":"10.1021\/acsnano.2c05306","volume":"16","author":"A Girish","year":"2022","unstructured":"Girish, A. et al. Platelet-inspired intravenous nanomedicine for injury-targeted direct delivery of thrombin to augment hemostasis in coagulopathies. ACS Nano 16, 16292\u201316313 (2022).","journal-title":"ACS Nano"},{"key":"1250_CR173","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1111\/jth.15734","volume":"20","author":"S Raghunathan","year":"2022","unstructured":"Raghunathan, S., Rayes, J. & Sen Gupta, A. Platelet-inspired nanomedicine in hemostasis thrombosis and thromboinflammation. J. Thromb. Haemost. 20, 1535\u20131549 (2022).","journal-title":"J. Thromb. Haemost."},{"key":"1250_CR174","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1182\/blood-2013-04-497123","volume":"123","author":"G Colucci","year":"2014","unstructured":"Colucci, G. et al. The effect of desmopressin on platelet function: a selective enhancement of procoagulant COAT platelets in patients with primary platelet function defects. Blood 123, 1905\u20131916 (2014).","journal-title":"Blood"},{"key":"1250_CR175","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1182\/blood.2023022928","volume":"144","author":"J Schaubaecher","year":"2024","unstructured":"Schaubaecher, J. et al. Procoagulant platelets promote immune evasion in triple negative breast cancer. Blood 144, 216\u2013226 (2024). Using clinical data and a sophisticated combination of live imaging and mouse tumour models, this study identified an unexpected role of procoagulant platelets in driving tumour growth.","journal-title":"Blood"}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41569-026-01250-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-026-01250-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-026-01250-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T12:01:58Z","timestamp":1781784118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41569-026-01250-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":175,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1250"],"URL":"https:\/\/doi.org\/10.1038\/s41569-026-01250-6","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"7 January 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}